Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
- Service Details
AVM Biotechnology is actively enrolling patients in an open-label adaptive design expansion cohort pivotal phase 1/2 study in relapsed/refractory non-hodgkin’s lymphoma and leukemia at major cancer treatment centers in the US.
- Directory Listing
Pharma Service: Clinical Trials
Sub Category: Phase I / IIa
How can we help you?
Please read our Privacy Policy carefully
Subscribe to our newsletter
Access Virtual Booth
Contact Supplier